AAAAAA
Results: 101-125/688
Authors:
KU YM
MIN DI
Citation: Ym. Ku et Di. Min, AN ABBREVIATED AREA-UNDER-THE-CURVE MONITORING FOR TACROLIMUS IN PATIENTS WITH LIVER-TRANSPLANTS, Therapeutic drug monitoring, 20(2), 1998, pp. 219-223
Authors:
PAN LP
ROSSEEL MT
BELPAIRE FM
Citation: Lp. Pan et al., COMPARISON OF 2 HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHODS FOR MONITORING PLASMA-CONCENTRATIONS OF HALOPERIDOL AND REDUCED HALOPERIDOL, Therapeutic drug monitoring, 20(2), 1998, pp. 224-230
Authors:
SMITH PF
PETROS WP
SOUCIE MP
COPELAND KR
Citation: Pf. Smith et al., NEW MODIFIED FLUORESCENCE POLARIZATION IMMUNOASSAY DOES NOT FALSELY ELEVATE VANCOMYCIN CONCENTRATIONS IN PATIENTS WITH END-STAGE RENAL-DISEASE, Therapeutic drug monitoring, 20(2), 1998, pp. 231-235
Authors:
JUBRAN RF
DINNDORF PA
Citation: Rf. Jubran et Pa. Dinndorf, SUCCESSFUL THERAPY OF REFRACTORY GRAFT-VERSUS-HOST DISEASE WITH TACROLIMUS AND PSORALEN PLUS ULTRAVIOLET-LIGHT, Therapeutic drug monitoring, 20(2), 1998, pp. 236-239
Authors:
TAYLOR PJ
LYNCH SV
BALDERSON GA
JOHNSON AG
Citation: Pj. Taylor et al., THERAPEUTIC DRUG-MONITORING OF TACROLIMUS (FK506) USING TANDEM MASS-SPECTROMETRY, Therapeutic drug monitoring, 20(2), 1998, pp. 240-241
Authors:
BATHUM L
HANSEN TS
HORDER M
BROSEN K
Citation: L. Bathum et al., A DUAL-LABEL OLIGONUCLEOTIDE LIGATION ASSAY FOR DETECTION OF THE CYP2C19-ASTERISK-1, CYP2C19-ASTERISK-2, AND CYP2C19-ASTERISK-3 ALLELES INVOLVING TIME-RESOLVED FLUOROMETRY, Therapeutic drug monitoring, 20(1), 1998, pp. 1-6
Authors:
EAP CB
LIMA CAD
MACCIARDI F
WOGGON B
POWELL K
BAUMANN P
Citation: Cb. Eap et al., STEADY-STATE CONCENTRATIONS OF THE ENANTIOMERS OF MIANSERIN AND DESMETHYLMIANSERIN IN POOR AND IN HOMOZYGOUS AND HETEROZYGOUS EXTENSIVE METABOLIZERS OF DEBRISOQUINE, Therapeutic drug monitoring, 20(1), 1998, pp. 7-13
Authors:
MEINEKE I
SCHREEB K
KRESS I
GUNDERTREMY U
Citation: I. Meineke et al., ROUTINE MEASUREMENT OF FLUOXETINE AND NORFLUOXETINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION IN PATIENTS UNDER CONCOMITANT TREATMENT WITH TRICYCLIC ANTIDEPRESSANTS, Therapeutic drug monitoring, 20(1), 1998, pp. 14-19
Authors:
ZUCCARO P
PACIFICI R
ALTIERI I
AVENOSO A
PELLEGRINI M
SPINA E
PERUCCA E
PICHINI S
Citation: P. Zuccaro et al., ISSUES IN METHODOLOGY AND APPLICATIONS FOR THERAPEUTIC DRUG-MONITORING OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS, Therapeutic drug monitoring, 20(1), 1998, pp. 20-24
Authors:
AKERMAN KK
JOLKKONEN J
HUTTUNEN H
PENTTILA I
Citation: Kk. Akerman et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHOD FOR ANALYZING CITALOPRAM AND DESMETHYLCITALOPRAM FROM HUMAN SERUM, Therapeutic drug monitoring, 20(1), 1998, pp. 25-29
Authors:
HACKETT LP
DUSCI LJ
ILETT KF
Citation: Lp. Hackett et al., A COMPARISON OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND FLUORESCENCE POLARIZATION IMMUNOASSAY FOR THERAPEUTIC DRUG-MONITORING OF TRICYCLIC ANTIDEPRESSANTS, Therapeutic drug monitoring, 20(1), 1998, pp. 30-34
Authors:
KINTZ P
TRACQUI A
MARZULLO C
DARREYE A
TREMEAU F
GRETH P
LUDES B
Citation: P. Kintz et al., ENANTIOSELECTIVE ANALYSIS OF METHADONE IN SWEAT AS MONITORED BY LIQUID-CHROMATOGRAPHY ION-SPRAY MASS-SPECTROMETRY, Therapeutic drug monitoring, 20(1), 1998, pp. 35-40
Authors:
SHUM YY
HUANG NJ
WALTER G
BLACK A
SEKERKE C
CHANG T
WHITFIELD LR
Citation: Yy. Shum et al., DEVELOPMENT, VALIDATION, AND INTERLABORATORY COMPARISON OF AN HMG-COAREDUCTASE INHIBITION ASSAY FOR QUANTITATION OF ATROVASTATIN IN PLASMAMATRICES, Therapeutic drug monitoring, 20(1), 1998, pp. 41-49
Authors:
REY E
PONS G
CREMIER O
VAUZELLEKERVROEDAN F
PARIENTEKHAYAT A
DATHIS P
BADOUAL J
OLIVE G
GENDREL D
Citation: E. Rey et al., ISONIAZID DOSE ADJUSTMENT IN A PEDIATRIC POPULATION, Therapeutic drug monitoring, 20(1), 1998, pp. 50-55
Authors:
BIALER M
LEVY RH
PERUCCA E
Citation: M. Bialer et al., DOES CARBAMAZEPINE HAVE A NARROW THERAPEUTIC PLASMA-CONCENTRATION RANGE, Therapeutic drug monitoring, 20(1), 1998, pp. 56-59
Authors:
CHETTY M
MILLER R
SEYMOUR MA
Citation: M. Chetty et al., PHENYTOIN AUTOINDUCTION, Therapeutic drug monitoring, 20(1), 1998, pp. 60-62
Authors:
DASGUPTA A
MCLEMORE JL
Citation: A. Dasgupta et Jl. Mclemore, ELEVATED FREE PHENYTOIN AND FREE VALPROIC ACID CONCENTRATIONS IN SERAOF PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Therapeutic drug monitoring, 20(1), 1998, pp. 63-67
Authors:
CROPP CD
DAVIS GA
ENSOM MHH
Citation: Cd. Cropp et al., EVALUATION OF AMINOGLYCOSIDE PHARMACOKINETICS IN POSTPARTUM PATIENTS USING BAYESIAN FORECASTING, Therapeutic drug monitoring, 20(1), 1998, pp. 68-72
Authors:
KOUP JR
ABEL RB
SMITHERS JA
ELDON MA
DEVRIES TM
Citation: Jr. Koup et al., EFFECT OF AGE, GENDER, AND RACE ON STEADY-STATE PROCAINAMIDE PHARMACOKINETICS AFTER ADMINISTRATION OF PROCANBID SUSTAINED-RELEASE TABLETS, Therapeutic drug monitoring, 20(1), 1998, pp. 73-77
Authors:
DENARO CP
JACOB P
BENOWITZ NL
Citation: Cp. Denaro et al., EVALUATION OF PHARMACOKINETIC METHODS USED TO ESTIMATE CAFFEINE CLEARANCE AND COMPARISON WITH A BAYESIAN FORECASTING METHOD, Therapeutic drug monitoring, 20(1), 1998, pp. 78-87
Authors:
RODRIGUEZMENDIZABAL M
LUCENA MI
CABELLO MR
BLANCO E
LOPEZRODRIGUEZ B
DELACUESTA FS
Citation: M. Rodriguezmendizabal et al., VARIATIONS IN BLOOD-LEVELS OF AMINOGLYCOSIDES RELATED TO IN-VITRO ANTICOAGULANT USAGE, Therapeutic drug monitoring, 20(1), 1998, pp. 88-91
Authors:
REITH D
MONTELEONE JPR
WHYTE IM
EBELLING W
HOLFORD NHG
CARTER GL
Citation: D. Reith et al., FEATURES AND TOXICOKINETICS OF CLOZAPINE IN OVERDOSE, Therapeutic drug monitoring, 20(1), 1998, pp. 92-97
Authors:
SKELTON H
DANN LM
ONG RTT
HAMILTON T
ILETT KF
Citation: H. Skelton et al., DRUG SCREENING OF PATIENTS WHO DELIBERATELY HARM THEMSELVES ADMITTED TO THE EMERGENCY DEPARTMENT, Therapeutic drug monitoring, 20(1), 1998, pp. 98-103
Authors:
DASGUPTA A
DATTA P
Citation: A. Dasgupta et P. Datta, RAPID DETECTION OF CARDIOACTIVE BUFALIN TOXICITY USING FLUORESCENCE POLARIZATION IMMUNOASSAY FOR DIGITOXIN, Therapeutic drug monitoring, 20(1), 1998, pp. 104-108
Authors:
VANAGTMAEL MA
BUTTER JJ
PORTIER EJG
VANBOXTEL CJ
Citation: Ma. Vanagtmael et al., VALIDATION OF AN IMPROVED REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY WITH REDUCTIVE ELECTROCHEMICAL DETECTION FOR THE DETERMINATION OF ARTEMISININ DERIVATIVES IN MAN, Therapeutic drug monitoring, 20(1), 1998, pp. 109-116